Because medulloblastomas are also known to be extremely radiosensitive[2], we hypothesized that MV-NIS virotherapy in combination with 131I could promote enhanced tumor regression and survival in our orthotopic models of localized and disseminated disease. This evidence concerns the gene SLC5A5 and medulloblastoma.